Nada Alsuhebany

7PUBLICATIONS
21CO-AUTHORS
HaematologyHaematological tumoursCardiology (incl. cardiovascular diseases)Predictive and prognostic markersRecommender systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 11, 2026
Effectiveness and safety of brentuximab vedotin-containing regimen versus standard chemotherapy in relapsed or refractory Hodgkin lymphoma: a multicenter cohort study.

|Apr 22, 2026
Assessment of the Correlation Between Hypoalbuminemia and Adverse Effects of Oral Anticancer Medications in Adult Patients with Solid Tumors: A Single-Center Retrospective Cohort Study in Saudi Arabia.

|Apr 03, 2026
Clinical Characteristics and Outcome of Diffuse Large B-Cell Lymphoma: Real-World Data From Saudi Arabia.

Abdullah M Alrajhi, Tariq AlQahtani, Jude Howaidi

|Mar 20, 2026
Assessing Thrombotic Risk in Patients with HR+/HER2- Breast Cancer Receiving CDK4/6 Inhibitors: Insights from Real-World Data from the Middle East.

Nada Alsuhebany, Ahmed Alanazi, Mohammed Y Alzahrani

|Feb 03, 2026
Evaluating the Readiness of Saudi Oncology Real-World Data for Standardization and Quality Enhancement.

Almaha Alfakhri, Ohoud Almadani, Ibrahim Asiri

|Aug 01, 2025
Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis.

Lama Alfehaid, Nada Alsuhebany, Hussah Albahlal

Pageof 2

Frequent Collaborators

2 joint publications

Lama Alfehaid

1 joint publications

Hussah Albahlal

1 joint publications

Albatoul Alomran

1 joint publications

Abdulmajeed M Alshehri